• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自人类胃癌的活化型c-raf-1基因的结构

Structure of the activated c-raf-1 gene from human stomach cancer.

作者信息

Shimizu K, Nakatsu Y, Nomoto S, Sekiguchi M

机构信息

Molecular Genetics Section, Faculty of Science, Kyushu University, Fukuoka, Japan.

出版信息

Princess Takamatsu Symp. 1986;17:85-91.

PMID:2843497
Abstract

We previously isolated a novel human transforming gene from a primary stomach cancer and identified it as an activated version of the c-raf-1 gene which is the human homologue of v-raf, a viral oncogene encoding a serine/threonine-specific protein kinase. Analyses of cDNA and genomic clones of this gene revealed that it was generated by substitution of 5'-sequence (exons 1-5) of the normal c-raf-1 gene with an unrelated human sequence. We identified the region in the genomic clone where the rearrangement had occurred. The rearranged EcoRI fragment was detected in all the primary transformants obtained from two independent transfections, suggesting that the recombination had occurred in the primary cancer. By sequence analysis of cDNA, the putative product of the transforming gene was inferred to have a hydrophobic stretch ahead of the ser/thr-protein kinase domain of the c-raf-1 gene product. We introduced one of the cDNA which contains the 1.6-kb open reading frame into the pUC9 vector. An autophosphorylating, 58 kd protein was induced in Escherichia coli cells bearing the plasmid upon induction. Since ser/thr-protein kinase activity of the normal c-raf protein has not been evidenced, these results suggest that the truncation/replacement of the amino-terminal domain of the c-raf-1 protein leads to constitutive activation of the protein kinase probably residing on the downstream domain.

摘要

我们先前从一例原发性胃癌中分离出一个新的人类转化基因,并将其鉴定为c-raf-1基因的激活形式,该基因是v-raf的人类同源物,v-raf是一种编码丝氨酸/苏氨酸特异性蛋白激酶的病毒癌基因。对该基因的cDNA和基因组克隆进行分析后发现,它是由正常c-raf-1基因的5'端序列(外显子1-5)被一段不相关的人类序列取代而产生的。我们确定了基因组克隆中发生重排的区域。在两次独立转染获得的所有原发性转化体中均检测到重排的EcoRI片段,这表明重组发生在原发性癌症中。通过对cDNA的序列分析,推测转化基因的推定产物在c-raf-1基因产物的丝氨酸/苏氨酸蛋白激酶结构域之前有一段疏水序列。我们将其中一个包含1.6kb开放阅读框的cDNA导入pUC9载体。携带该质粒的大肠杆菌细胞在诱导后可诱导产生一种自磷酸化的58kd蛋白。由于尚未证实正常c-raf蛋白具有丝氨酸/苏氨酸蛋白激酶活性,这些结果表明c-raf-1蛋白氨基末端结构域的截短/替换可能导致可能位于下游结构域的蛋白激酶的组成性激活。

相似文献

1
Structure of the activated c-raf-1 gene from human stomach cancer.来自人类胃癌的活化型c-raf-1基因的结构
Princess Takamatsu Symp. 1986;17:85-91.
2
[Activated c-raf-1 gene from human stomach cancer].[源自人类胃癌的活化c-raf-1基因]
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 2):2140-6.
3
Activation of rat and human c-raf(-1) by rearrangement.
Princess Takamatsu Symp. 1986;17:75-84.
4
Identification of a transforming activity suppressing sequence in the c-raf oncogene.在c-raf癌基因中鉴定出一种转化活性抑制序列。
Oncogene. 1988 Dec;3(6):653-8.
5
The complete primary structure of the rat A-raf cDNA coding region: conservation of the putative regulatory regions present in rat c-raf.大鼠A-raf cDNA编码区的完整一级结构:大鼠c-raf中假定调控区的保守性。
Oncogene Res. 1987 Aug;1(3):243-53.
6
A mechanism of c-raf-1 activation: fusion of the lipocortin II amino-terminal sequence with the c-raf-1 kinase domain.c-raf-1激活的一种机制:脂皮质素II氨基末端序列与c-raf-1激酶结构域的融合。
Oncogene. 1989 Apr;4(4):437-42.
7
raf oncogenes in carcinogenesis.致癌过程中的raf癌基因。
Crit Rev Oncog. 1990;2(1):1-8.
8
Genomic organization and nucleotide sequence of the coding region of the chicken c-Rmil(B-raf-1) proto-oncogene.鸡c-Rmil(B-raf-1)原癌基因编码区的基因组结构和核苷酸序列。
Biochem Biophys Res Commun. 1993 Jun 30;193(3):1324-31. doi: 10.1006/bbrc.1993.1770.
9
Identification by a random linker insertion method of a region which suppresses the transforming activity of the raf oncogene.通过随机连接子插入法鉴定出一个抑制raf癌基因转化活性的区域。
Nucleic Acids Symp Ser. 1988(19):39-42.
10
[ret gene from a human stomach cancer].[来自人类胃癌的ret基因]
Hokkaido Igaku Zasshi. 1988 Nov;63(6):913-24.

引用本文的文献

1
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.一项评估利鲁唑和索拉非尼用于晚期实体瘤患者的 I 期临床试验:CTEP #8850。
Oncotarget. 2023 Apr 10;14:302-315. doi: 10.18632/oncotarget.28403.
2
CRAF R391W is a melanoma driver oncogene.CRAF R391W是一种黑色素瘤驱动癌基因。
Sci Rep. 2016 Jun 8;6:27454. doi: 10.1038/srep27454.
3
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.致癌性RAF1重排和一种新型BRAF突变作为KIAA1549:BRAF融合的替代机制,在毛细胞型星形细胞瘤中激活丝裂原活化蛋白激酶(MAPK)通路
Oncogene. 2009 May 21;28(20):2119-23. doi: 10.1038/onc.2009.73. Epub 2009 Apr 13.